Over the course of this series so far we’ve looked at the role of the microbiome in two of the three major…
Read MoreWith the rise of next-generation sequencing and the increase of big data, scientists have gained a deeper understanding of various diseases….
Read MoreThe key to fighting chronic diseases is connecting the multitude of scientific and technological advances to diagnostics and therapeutics. Experts have…
Read MoreHow difficult can antibiotic drug discovery be? Some of those struggling with their drug discovery projects in other areas might find…
Read MoreWe previously discussed some of the failures in drug discovery for several chronic diseases. Now, we explore the partnerships that have…
Read MoreIt’s a long, hard road that begins with the identification of a promising drug candidate and ends with its introduction to…
Read MoreWith the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors are formed….
Read More“The $1000 Pill.” “The Quest: $84,000 Miracle Cure Costs Less Than $150 to Make.” “A Billion a Year for Costly Drug…
Read MoreThere’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country….
Read MoreAssay Depot released a press release announcing it raised $3 million in Series B Funds to “Grow Science as a Server”…
Read More